200 related articles for article (PubMed ID: 37954960)
1. Exploring the disruption of SARS-CoV-2 RBD binding to hACE2.
Carter C; Airas J; Gladden H; Miller BR; Parish CA
Front Chem; 2023; 11():1276760. PubMed ID: 37954960
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
Nayak SK
Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
[TBL] [Abstract][Full Text] [Related]
3. Improved Binding Affinity of Omicron's Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence.
Kumar R; Murugan NA; Srivastava V
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328828
[TBL] [Abstract][Full Text] [Related]
4. Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2.
Chen X; Wang Z; Wang J; Yao Y; Wang Q; Huang J; Xiang X; Zhou Y; Xue Y; Li Y; Gao X; Wang L; Chu M; Wang Y
Front Pharmacol; 2022; 13():940628. PubMed ID: 36003511
[TBL] [Abstract][Full Text] [Related]
5. E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies.
Wang WB; Liang Y; Jin YQ; Zhang J; Su JG; Li QM
J Mol Graph Model; 2021 Dec; 109():108035. PubMed ID: 34562851
[TBL] [Abstract][Full Text] [Related]
6. Insight into the origin of SARS-CoV-2 through structural analysis of receptor recognition: a molecular simulation study.
Sun J; Liu M; Yang N
RSC Adv; 2021 Feb; 11(15):8718-8729. PubMed ID: 35423354
[TBL] [Abstract][Full Text] [Related]
7. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor.
Zhang Y; He X; Zhai J; Ji B; Man VH; Wang J
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013346
[TBL] [Abstract][Full Text] [Related]
8. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V
F1000Res; 2020; 9():576. PubMed ID: 32802318
[No Abstract] [Full Text] [Related]
9. Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2.
Sakib MMH; Nishat AA; Islam MT; Raihan Uddin MA; Iqbal MS; Bin Hossen FF; Ahmed MI; Bashir MS; Hossain T; Tohura US; Saif SI; Jui NR; Alam M; Islam MA; Hasan MM; Sufian MA; Ali MA; Islam R; Hossain MA; Halim MA
Comput Biol Med; 2021 Sep; 136():104759. PubMed ID: 34403938
[TBL] [Abstract][Full Text] [Related]
10. Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2.
Chen C; Boorla VS; Banerjee D; Chowdhury R; Cavener VS; Nissly RH; Gontu A; Boyle NR; Vandegrift K; Nair MS; Kuchipudi SV; Maranas CD
Proc Natl Acad Sci U S A; 2021 Oct; 118(42):. PubMed ID: 34588290
[TBL] [Abstract][Full Text] [Related]
11. Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex.
Kumawat N; Tucs A; Bera S; Chuev GN; Valiev M; Fedotova MV; Kruchinin SE; Tsuda K; Sljoka A; Chakraborty A
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164065
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics analysis predicts ritonavir and naloxegol strongly block the SARS-CoV-2 spike protein-hACE2 binding.
Bagheri M; Niavarani A
J Biomol Struct Dyn; 2022 Mar; 40(4):1597-1606. PubMed ID: 33030105
[TBL] [Abstract][Full Text] [Related]
13. A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2.
Wang X; Yang C; Sun Y; Sui X; Zhu T; Wang Q; Wang S; Yang J; Yang W; Liu F; Zhang M; Wang Y; Luo Y
Environ Int; 2021 Feb; 147():106361. PubMed ID: 33401173
[TBL] [Abstract][Full Text] [Related]
14. Interfacial Water in the SARS Spike Protein: Investigating the Interaction with Human ACE2 Receptor and In Vitro Uptake in A549 Cells.
Singh AV; Kayal A; Malik A; Maharjan RS; Dietrich P; Thissen A; Siewert K; Curato C; Pande K; Prahlad D; Kulkarni N; Laux P; Luch A
Langmuir; 2022 Jul; 38(26):7976-7988. PubMed ID: 35736838
[TBL] [Abstract][Full Text] [Related]
15. Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2.
Miluzio A; Cuomo A; Cordiglieri C; Donnici L; Pesce E; Bombaci M; Conti M; Fasciani A; Terracciano L; Manganaro L; Toccafondi M; Scagliola A; Oliveto S; Ricciardi S; Grifantini R; De Francesco R; Abrignani S; Manfrini N; Biffo S
EBioMedicine; 2023 Jan; 87():104390. PubMed ID: 36584595
[TBL] [Abstract][Full Text] [Related]
16. Fruit Bromelain-Derived Peptide Potentially Restrains the Attachment of SARS-CoV-2 Variants to hACE2: A Pharmacoinformatics Approach.
Tallei TE; Fatimawali ; Adam AA; Elseehy MM; El-Shehawi AM; Mahmoud EA; Tania AD; Niode NJ; Kusumawaty D; Rahimah S; Effendi Y; Idroes R; Celik I; Hossain MJ; Emran TB
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011492
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of 7-azaindole derivatives as inhibitors of the SARS-CoV-2 spike-hACE2 protein interaction.
Wang C; He F; Sun K; Guo K; Lu S; Wu T; Gao X; Fang M
Int J Biol Macromol; 2023 Jul; 244():125182. PubMed ID: 37276898
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.
Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S
Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301
[TBL] [Abstract][Full Text] [Related]
19. Novel Inhibitory Role of Fenofibric Acid by Targeting Cryptic Site on the RBD of SARS-CoV-2.
Huang J; Chan KC; Zhou R
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830728
[TBL] [Abstract][Full Text] [Related]
20. Emerging of composition variations of SARS-CoV-2 spike protein and human ACE2 contribute to the level of infection:
AlGhamdi NA; Alsuwat HS; Borgio JF; AbdulAzeez S
J Biomol Struct Dyn; 2022 Apr; 40(6):2635-2646. PubMed ID: 33138699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
